Lina Okar

Lina Okar

Auto-generated profile, based on publicly available information

Lina Okar

Department of Neurology SSM Health/Saint Louis University Saint Louis Missouri USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
SSSundus Sardar
Sundus Sardar
ASAbeer Safan
Abeer Safan
LOLina Okar
Lina Okar
NSNagham Sadik
Nagham Sadik
GAGholam Adeli
Gholam Adeli
Owing to autoantibody production and thrombophilic disorders in COVID‐19, physicians must have low threshold to investigate secondary IIH and demyelinating disorders in patients with headache and decreased vision following recent COVID‐19 infection.

1 December 2020 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
LOLina Okar
Lina Okar
MAMohammad Ali
Mohammad Ali
JPJabeed Parengal
Jabeed Parengal
MYMohamed A. Yassin
Mohamed A. Yassin
Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.

16 November 2020 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
LOLina Okar
Lina Okar
MAMaya Aldeeb
Maya Aldeeb
MYMohamed Yassin
Mohamed Yassin
Due to the overlap between ACS and COVID‐19 pneumonia, we recommend close monitoring for those patients and offering them RBC exchange early in the course of the disease to avoid clinical deterioration.

18 January 2022 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
MAMaya Aldeeb
Maya Aldeeb
LOLina Okar
Lina Okar
SMSafa S. Mahmud
Safa S. Mahmud
GAGholam A. Adeli
Gholam A. Adeli
Due to SARS‐COV‐2 (COVID‐19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. Possible rare side effects could not have been observed in this relatively short period. We are reporting an elderly lady with multiple comorbidities who presented with progressive lower limb weakness that started seven days after receiving the first dose of the COVID‐19 vaccine. The electrodiagnostic study showed demyelinating polyneuropathy with secondary axonal degeneration consistent with Guillain–Barré syndrome. We ruled out other possible causes for GBS, suggesting a postvaccine nature for her presentation. The patient received intravenous immunoglobulin (IVIG) for five days and gradually improved, which supports our initial diagnosis.

29 June 2020 in Cureus
Verified
Journal Article
Open access
PDF file
MAMohammad Ali
Mohammad Ali
LOLina Okar
Lina Okar
PIPhool Iqbal
Phool Iqbal
MYMohamed Yassin
Mohamed Yassin
Secondary iron overload in patients with chronic kidney disease (CKD) due to iatrogenic iron replacement is an emerging medical challenge. There are limited options to manage secondary iron overload in patients with CKD as most iron chelators are contraindicated due to low creatinine clearance. In addition to that, accuracy of serum ferritin in monitoring is questionable since it is affected by different variables including inflammation and liver disease. Moreover, correlation of serum ferritin with liver iron concentration (LIC) and heart iron concentration is not well studied in CKD patients. There is no established cut-off value in the current guidelines, and this warrants further investigation with more accurate methods. There are few studies that evaluated the relationship between serum ferritin and LIC determined by different MRI protocols. Limited data in the literature concluded that a positive correlation exists between serum ferritin and LIC determined by MRI T2* and that serum ferritin more than 290 mcg/L is equivalent to severe iron overload on MRI T2*. However, we had a different observation of a patient with CKD on a prolonged course of iron replacement who was monitored with serum ferritin, and despite having a serum ferritin level of more than 1,000 mcg/L, LIC determined by MRI T2* was 5.3 mg/g of liver dry tissue, which is equivalent to mild iron overload. This observation opens the door for further studies to examine the correlation between serum ferritin and LIC determined by MRI and to establish a safe cut-off value of serum ferritin so that further investigation would be indicated in patients with CKD.

1 April 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
LOLina Okar
Lina Okar
MRMohamad Rezek
Mohamad Rezek
AGAmna Gameil
Amna Gameil
YMYahya Mulikandayhil
Yahya Mulikandayhil
MYMohamed Yassin
Mohamed Yassin
Even though most data suggest favorable outcome in patients with SCD and COVID-19 infection, close monitoring remains essential as acute complication may develop unexpectedly. Offering RBC exchange early in the course of infection might improve prognosis.